Saudi Arabia announced initiating efforts to undertake the production of insulin in the country, with the signing of a preliminary agreement on this at the Global Health Forum in Riyadh.
The agreement came in partnership with the Local Content and Government Procurement Authority and the Spending Efficiency and Government Projects Authority (Expro) by activating the contracting method for the localisation of the industry and the transfer of knowledge.
The agreement was concluded by the National Company for the Unified Purchase of Medicines, Medical Devices and Supplies (NUPCO), Sudair Pharmaceuticals Company, and Sanofi Company.
The pact is expected to maximise the government’s purchasing power and achieve self-sufficiency in a number of priority products and sectors through localisation of the manufacture of some insulin products.
The Global Health Forum, scheduled to close on Tuesday, is expected to see more investment agreements in the health sector and medical technologies.
Follow us on
